Skip to main content

Table 1 Inhibition by HR1 and HR2 peptide inhibitors and sCD4

From: Mutations of Glu560 within HIV-1 Envelope Glycoprotein N-terminal heptad repeat region contribute to resistance to peptide inhibitors of virus entry

Inhibitor selection

Mutants

N36 (μM)

IZN36 (nM)

T20 (nM)

sCD4 (μg/mL)

IC50 ± SD

Ratio

IC50 ± SD

Ratio

IC50 ± SD

Ratio

IC50 ± SD

Ratio

N36/IZN36

LAIwt

1.77 ± 0.22

1.00

29.3 ± 8.95

1.00

251.14 ± 59.67

1.00

4.85 ± 0.015

1.00

E560K

6.52 ± 0.43

3.68

59.86 ± 12.93

2.04

148.89 ± 58.78

0.60

1.05 ± 0.010

0.21

T20

E560D

2.81 ± 0.55

1.58

23.15 ± 1.24

0.93

135.92 ± 36.69

0.54

1.37 ± 0.10

0.28

E560G

0.55 ± 0.07

0.31

11.22 ± 0.90

0.29

87.66 ± 21.48

0.24

2.98 ± 0.010

0.61

  1. The ratio is IC50 for the indicated pseudovirus/LAIwt pseudovirus